|
Volumn 198, Issue 2, 2013, Pages 77-
|
Rethinking psychotropics in nursing homes: While evidence supports psychotropic use in nursing homes in some scenarios, we use them too often, for too long, at doses too high and in dangerous combinations with other medications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
HYPNOTIC AGENT;
NEUROLEPTIC AGENT;
PLACEBO;
PSYCHOTROPIC AGENT;
SEDATIVE AGENT;
AUSTRALIA;
BEHAVIOR DISORDER;
BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOM OF DEMENTIA;
DEMENTIA;
DEPRESSION;
DRUG SAFETY;
DRUG USE;
GERIATRIC CARE;
HEALTH CARE MANAGEMENT;
HEALTH ECONOMICS;
HUMAN;
INVESTMENT;
MEDICAL ETHICS;
MENTAL DISEASE;
MORTALITY;
NOTE;
NURSING HOME;
PATIENT AUTONOMY;
SCHIZOPHRENIA;
SLEEP DISORDER;
AGED;
AUSTRALIA;
HOMES FOR THE AGED;
HUMANS;
NURSING HOMES;
PSYCHOTROPIC DRUGS;
|
EID: 84874589933
PISSN: 0025729X
EISSN: 13265377
Source Type: Journal
DOI: 10.5694/mja12.11593 Document Type: Note |
Times cited : (30)
|
References (9)
|